2009-07-13T13:05:00
Unregulated pharmaceuticals may be allowed to inflate the NHS drugs bill for little benefit to patients according to independent health policy analyst Roy Lilley.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud